EGFR and non-small cell lung carcinoma: The results demonstrated that AC0010 exhibits a stronger inhibitory effect on EGFR-mutant NSCLC cells harboring the T790M mutation and overlooked EGFR-wild-type NSCLC cells and normal cells.